U.S. Markets closed

Kelyniam Global, Inc. (KLYG)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.11720.0000 (0.00%)
At close: 09:30AM EST

Kelyniam Global, Inc.

97 River Road
Suite A
Collinsville, CT 06019
United States
800 280 8192

IndustryMedical Devices
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Ross BjellaChairman & CEON/AN/A1962
Mr. Terrance KurtenbachChief Financial OfficerN/AN/AN/A
Mr. Christopher BreaultCOO & DirectorN/AN/AN/A
Michael HamblettDirector of Investor RelationsN/AN/AN/A
Mr. James Barrow Esq.Gen. Counsel and Director of Quality & RegulatoryN/AN/AN/A
Dr. Mark V. SmithVP of Sales & Bus. Devel. and DirectorN/AN/AN/A
Dr. Christopher MiruckiChief Medical OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers. The company develops, manufactures, and distributes custom cranial and craniofacial fixation screws for patients requiring the reconstruction of cranial and facial structures. It serves health systems, hospitals, sales representative, and surgeons, payors, and patients. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. The company was incorporated in 2005 and is based in Collinsville, Connecticut.

Corporate Governance

Kelyniam Global, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.